Skip to main content
British Heart Journal logoLink to British Heart Journal
. 1993 Jul;70(1):4. doi: 10.1136/hrt.70.1.4

Why inotropes continue to disappoint in heart failure.

P Wilmshurst
PMCID: PMC1025218  PMID: 8037996

Full text

PDF

Page 4

4

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Curfman G. D. Inotropic therapy for heart failure--an unfulfilled promise. N Engl J Med. 1991 Nov 21;325(21):1509–1510. doi: 10.1056/NEJM199111213252111. [DOI] [PubMed] [Google Scholar]
  2. DiBianco R., Shabetai R., Kostuk W., Moran J., Schlant R. C., Wright R. A comparison of oral milrinone, digoxin, and their combination in the treatment of patients with chronic heart failure. N Engl J Med. 1989 Mar 16;320(11):677–683. doi: 10.1056/NEJM198903163201101. [DOI] [PubMed] [Google Scholar]
  3. Foult J. M., Tavolaro O., Antony I., Nitenberg A. Direct myocardial and coronary effects of enalaprilat in patients with dilated cardiomyopathy: assessment by a bilateral intracoronary infusion technique. Circulation. 1988 Feb;77(2):337–344. doi: 10.1161/01.cir.77.2.337. [DOI] [PubMed] [Google Scholar]
  4. Gillis R. A., Helke C. J., Kellar K. J., Quest J. A. Autonomic nervous system actions of cardiac glycosides. Biochem Pharmacol. 1978 Mar 15;27(6):849–856. doi: 10.1016/0006-2952(78)90408-2. [DOI] [PubMed] [Google Scholar]
  5. Gwathmey J. K., Copelas L., MacKinnon R., Schoen F. J., Feldman M. D., Grossman W., Morgan J. P. Abnormal intracellular calcium handling in myocardium from patients with end-stage heart failure. Circ Res. 1987 Jul;61(1):70–76. doi: 10.1161/01.res.61.1.70. [DOI] [PubMed] [Google Scholar]
  6. Packer M., Carver J. R., Rodeheffer R. J., Ivanhoe R. J., DiBianco R., Zeldis S. M., Hendrix G. H., Bommer W. J., Elkayam U., Kukin M. L. Effect of oral milrinone on mortality in severe chronic heart failure. The PROMISE Study Research Group. N Engl J Med. 1991 Nov 21;325(21):1468–1475. doi: 10.1056/NEJM199111213252103. [DOI] [PubMed] [Google Scholar]
  7. Poole-Wilson P. A., Robinson K. Digoxin--a redundant drug in congestive cardiac failure. Cardiovasc Drugs Ther. 1989 Jan;2(6):733–741. doi: 10.1007/BF00133201. [DOI] [PubMed] [Google Scholar]
  8. Schaal S. F., Sugimoto T., Wallace A. G., Sealy W. C. Effects of digitalis on the functional refractory period of the AV node: studies in awake dogs with and without cardiac denervation. Cardiovasc Res. 1968 Oct;2(4):356–359. doi: 10.1093/cvr/2.4.356. [DOI] [PubMed] [Google Scholar]
  9. Uretsky B. F., Jessup M., Konstam M. A., Dec G. W., Leier C. V., Benotti J., Murali S., Herrmann H. C., Sandberg J. A. Multicenter trial of oral enoximone in patients with moderate to moderately severe congestive heart failure. Lack of benefit compared with placebo. Enoximone Multicenter Trial Group. Circulation. 1990 Sep;82(3):774–780. doi: 10.1161/01.cir.82.3.774. [DOI] [PubMed] [Google Scholar]
  10. Wilmshurst P. T., Walker J. M., Fry C. H., Mounsey J. P., Twort C. H., Williams B. T., Davies M. J., Webb-Peploe M. M. Inotropic and vasodilator effects of amrinone on isolated human tissue. Cardiovasc Res. 1984 May;18(5):302–309. doi: 10.1093/cvr/18.5.302. [DOI] [PubMed] [Google Scholar]

Articles from British Heart Journal are provided here courtesy of BMJ Publishing Group

RESOURCES